Novo Nordisk Wins EU Approval for First Oral GLP-1 Weight-Loss Drug Wegovy Written By MD Bureau16 July 2026 6:28 PM ISTBengaluru: Novo Nordisk said on Wednesday the European Commission approved its once-daily Wegovy pill for weight management in adults with obesity or...
EMA Backs Novo Nordisk's Oral Wegovy, Paving Way for Europe's First Weight-Loss Pill Written By sheeba farhat25 May 2026 10:30 AM ISTLondon: The European Medicines Agency recommended approval of Novo Nordisk's pill Wegovy, the regulator said on Friday, clearing the way for it to...
Novo Nordisk Nears Europe Launch of Oral Wegovy After EMA Recommendation Written By sheeba farhat23 May 2026 5:02 PM ISTLondon: The European Medicines Agency recommended approval of Novo Nordisk's pill Wegovy, the regulator said on Friday, clearing the way for it to...
Retatrutide Shows Remarkable Weight Loss in Phase 3 TRIUMPH-1 Trial Written By Dr Kartikeya Kohli23 May 2026 8:45 AM ISTIn the phase 3 TRIUMPH-1 trial, 2339 adults with obesity or overweight and at least one weight-related comorbidity were randomized to receive...
Eli Lilly's Foundayo Sees Slow Start in U.S., Trails Novo Nordisk's Wegovy in Early Prescription Race Written By sheeba farhat2 May 2026 10:00 AM ISTBengaluru: Eli Lilly's newly launched oral weight-loss drug, Foundayo, was prescribed 5,612 times in the U.S. in the third week after its launch,...
Lilly's Foundayo Clocks 1,390 Prescriptions in Debut Week as Oral Obesity Drug Race Heats Up Written By sheeba farhat19 April 2026 12:09 PM ISTNew Delhi: Eli Lilly's newly launched weight-loss pill was prescribed 1,390 ‌times in the U.S. in its first week of sales, according to analysts who...
USFDA Flags Liver Safety Concerns, Asks Eli Lilly for Additional Data on Obesity Pill Foundayo Written By sheeba farhat15 April 2026 7:35 PM ISTNew Delhi: The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury linked to its newly approved ​obesity pill,...
USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk Written By sheeba farhat3 April 2026 2:49 PM ISTWashington: The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up the next battle with Novo Nordisk for the millions of...
FDA Approves Orforglipron as Second Oral GLP-1 Agonist for Weight Loss Written By Dr. Kamal Kant Kohli2 April 2026 11:00 AM ISTThe FDA has approved Orforglipron as the second oral GLP-1 receptor agonist for weight management in adults with obesity or overweight with...
